ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,349.20
      -0.34%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.39
      -0.23%
      Bitcoin
      63,886.43
      -0.59%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Synthetic Biologics Inc (SYN) Quote

      Synthetic Biologics Inc

      Synthetic Biologics Inc (SYN)

      Synergia Energy Ltd
      Synergia Energy Ltd
      1.02
      0.00
      (0.00%)
      Closed September 24 4:00PM
      Delayed by 15 minutes
      1.02
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.02
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      17.384M
      Previous Close
      1.02
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,043,000
      Dividend Yield
      -
      PE Ratio
      -3.03
      Earnings Per Share (EPS)
      -1.08
      Revenue
      -
      Net Profit
      -18.35M

      About Synthetic Biologics Inc

      Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio... Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Business Services
      Website
      www.syntheticbiologics.com
      Headquarters
      Rockville, Maryland, USA
      Founded
      1993

      Ask ADVFN Intelligence (AI)

      SYN Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      20 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      20 hours ago

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference PR Newswire ROCKVILLE, Md., Feb. 9, 2022 ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE...

      February 09 2022
      PR Newswire (US)

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA Follows recent announcement of planned acquisition of VCN Biosciences...

      February 08 2022
      PR Newswire (US)

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022 PR Newswire ROCKVILLE, Md., Jan. 26, 2022 ROCKVILLE, Md., Jan. 26, 2022 /PRNewswire/ -- Synthetic...

      January 26 2022
      PR Newswire (US)

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors Lead drug candidate...

      December 14 2021
      PR Newswire (US)

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Initiated a Phase 1 Multiple Ascending Dose Clinical...

      November 03 2021
      PR Newswire (US)

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021 -- Conference Call Scheduled for Wednesday, November 3, 2021 at 4:30 p.m. ET...

      October 26 2021
      PR Newswire (US)

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase Topline Data Readout Expected in Q2 2022 Phase 1 Clinical...

      October 21 2021
      PR Newswire (US)

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum The Company Encourages All Shareholders of Record Who Have Not Yet Voted to Do So by...

      October 06 2021
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ATCHAtlasClear Holdings Inc
      $ 0.3145
      (63.29%)
      		5.24M
      EMMGlobal X Emerging Markets ex China ETF
      $ 46.12
      (58.99%)
      		30
      OPTTOcean Power Technologies Inc
      $ 0.2012
      (13.29%)
      		5.71k
      MWGMulti Ways Holdings Limited
      $ 0.51
      (12.88%)
      		300
      KAPAKairos Pharma Ltd
      $ 2.24
      (11.44%)
      		52.9k
      BQBoqii Holding Limited
      $ 0.3024
      (-18.27%)
      		8
      YINNDirexion Daily FTSE China Bull 3X Shares
      $ 29.00
      (-11.72%)
      		219.98k
      XPPProShares Ultra FTSE China 50
      $ 17.83
      (-8.61%)
      		324
      CWEBDirexion Daily Csi China Internet Index Bull 2x Shares
      $ 32.90
      (-7.82%)
      		9.06k
      KTECKraneshares Hang Seng Tech Index Etf
      $ 12.30
      (-6.04%)
      		327
      ATCHAtlasClear Holdings Inc
      $ 0.3145
      (63.29%)
      		5.24M
      YANGDirexion Daily FTSE China Bear 3X Shares New
      $ 5.545
      (11.12%)
      		703.58k
      FXIiShares China Large Cap
      $ 29.20
      (-3.95%)
      		524.84k
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 34.49
      (-1.65%)
      		509.52k
      KWEBKraneShares CSI China Internet
      $ 28.80
      (-4.13%)
      		370.99k

      Discussion

      View Full Feed
      Retire43 Retire43 4 minutes ago
      Peer reviewed

      https://finance.yahoo.com/news/bioxytrans-medical-breakthrough-fighting-viruses-133500730.html/
      BIXT
      RuudSaltis RuudSaltis 5 minutes ago
      You asked to update the latest fintel short figure. Here it is :20,370,986 .
      ASTS
      Retire43 Retire43 7 minutes ago
      Look at this


      Cytta Corp
      cytta.com
      $CYCA
      Thus company is beginning to generate revenue!

      https://smallcapvip.com/investing-in-safety-how-personal-security-technologies-like-cyttacares-and-bsafe-are-shaping-the-future/
      CYCA
      RuudSaltis RuudSaltis 8 minutes ago
      Fintel latest short count: 20,370,986 . So approx 400.00 less.
      LWLG
      Retire43 Retire43 10 minutes ago
      http://www.marketwired.com/press-release/smartmetric-inc-vs-mastercard-visa-in-134-billion-patent-infringement-case-otcqb-smme-1822248.htm
      SMME
      tw0122 tw0122 15 minutes ago
      Pump and dump
      ATCH
      Murphydog25 Murphydog25 16 minutes ago
      🤦‍♂️
      TXTM
      Ribo Ribo 19 minutes ago
      https://x.com/OtcUpdates/status/1838791326235558166
      BDPT
      CanItBThisEZ2Make CanItBThisEZ2Make 23 minutes ago
      $AZRH IS NOW PINK CURRENT ====>
      https://www.otcmarkets.com/stock/AZRH/overview

      GO AZRH$
      AZRH
      thistraderknowsall thistraderknowsall 29 minutes ago
      NKN altcoin explodes exponentially to $1+ South Korea’s central bank, the Bank of Korea, will soon allow participants to use digital tokens for payments at supermarkets and convenience stores.
      Den Den 31 minutes ago
      I don’think so … low volume … we’ll be back up fast…. If pr train starts … we’ll be off to the races …
      Bring it on Dave 😊

      Go $BLEG
      BLEG
      gregcod gregcod 37 minutes ago
      Yes Tom16 and you are right...SomethinIm not selling any shares and who in their right mind would?..Scared newbees possibly..but we longs know what we own..We want the results of the testing being done currently at the US Mag plant, plus any other good news..Whats up doc?..Iris?...Has to come soon.I
      IBATF
      TRUISM TRUISM 42 minutes ago
      Harvest will be very telling indeed...

      Reminiscent of 2013-2023:

      https://external-content.duckduckgo.com/iu/?u=https%3A%2F%2Ftse1.mm.bing.net%2Fth%3Fid%3DOIP.UQao-xwVjeiLNIAt_UTJywHaFj%26pid%3DApi&f=1&ipt=6ad1ffb6b96cb0269b4044cdb68a34671682d3b4cd3d9562ac229a80e4f4a0f8
      KBLB
      misterfishman misterfishman 50 minutes ago
      I hope your dreams come true you have waited long enough.
      IGPK
      nowwhat2 nowwhat2 55 minutes ago
      This here is NEWS........It's NOT me "on a pulpit"
      It's BITCOINS' REACTION TO its' 200 day moving average


      https://investorshub.advfn.com/uimage/uploads/2024/9/25/geyemIHUB_PULPIT_SHELLY.jpg




      The board is for discussion.....
      BTCUSD
      DR_rugby DR_rugby 55 minutes ago
      Did you buy and hodl?

      https://m.youtube.com/watch?v=N8AGt4_P4Ys

      Infinite risk

      GLTA
      GME
      TRUSTUNITS1000000 TRUSTUNITS1000000 59 minutes ago
      A while back 0.0001 to under .10
      FMNJ
      TRUSTUNITS1000000 TRUSTUNITS1000000 59 minutes ago
      Preparing to prepare
      FMNJ
      TRUSTUNITS1000000 TRUSTUNITS1000000 60 minutes ago
      Management maybe dead
      FMNJ
      TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
      Shareholders post
      ONCI
      TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
      A million shares
      ONCI
      TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
      Wowwwwww 0.0001
      ONCI
      TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
      Neat product
      Bigfootbud Bigfootbud 1 hour ago
      Touch The Sky http://mobilesavior.com/audio/touchthesky.mp3
      https://investorshub.advfn.com/uimage/uploads/2024/9/25/jxrhztouchthesky.jpg
      http://mobilesavior.com/#music

      💖💖💖💖💖💖💖💖💖💖💖&#x
      TRUSTUNITS1000000 TRUSTUNITS1000000 1 hour ago
      Shareholders Post

      Your Recent History

      AMEX
      SYN
      Synthetic Biologics
      Delayed Upgrade Clock